Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating Expenses:
Loss on legal settlement	$ 142,600
General and administrative	2,604,751	2,179,160
Total Operating Expenses	4,325,346	4,175,333
Loss From Operations	(4,325,346)	(4,175,333)
Other (Expense) Income:
Change in fair value of derivative liability	10,900
Gain on extinguishment of note payable	41,920
Total Other Expense	(995,866)	(992,415)
Net Loss	(5,321,212)	(5,167,748)
Dividend attributable to Series A, Series B, and Series C preferred stockholders	(1,228,685)	(1,157,486)
Net Loss Applicable to Common Stockholders	$ (6,549,897)	$ (6,325,234)
Net Loss Per Common Share - Basic	$ (0.17)	$ (0.18)
Net Loss Per Common Share - Diluted	$ (0.17)	$ (0.18)
Weighted Average Common Shares Outstanding - Basic	37,786,410	34,836,169
Weighted Average Common Shares Outstanding - Diluted	37,786,410	34,836,169
Nonrelated Party [Member]
Operating Expenses:
Research and development	$ 1,519,995	$ 1,938,173
Other (Expense) Income:
Interest expense	(135,246)	(170,868)
Interest expense - amortization of debt discount	(126,364)	(136,356)
Related Party [Member]
Operating Expenses:
Research and development	58,000	58,000
Other (Expense) Income:
Interest expense	(532,871)	(536,247)
Interest expense - amortization of debt discount	$ (254,205)	$ (148,944)